Example: Heart Attack

Clinical Trials on Coxsackievirus Infections

Total 55 results

NCT04533906

Recruiting

Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses

Conditions: Common Cold; Viral Infection
NCT04467541

Enrolling by invitation

Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71months

Conditions: Hand Foot & Mouth Disease
NCT04303169

Recruiting

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C)

Conditions: Melanoma
NCT04182932

Recruiting

Safety and Immunogenicity of CJ-40010 in Healthy Subjects

Conditions: Hand, Foot and Mouth Disease
NCT04152863

Recruiting

Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Conditions: Advanced/Metastatic Melanoma
NCT04133584

Recruiting

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Conditions: Seasonal Influenza; Hand, Foot and Mouth Disease
NCT04111432

Recruiting

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Conditions: Hand, Foot and Mouth Disease
NCT03909074

Completed

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

Conditions: Hand, Foot and Mouth Disease
NCT03903926

Active, not recruiting

Efficacy Trial of a Commercial EV71 Vaccine

Conditions: Hand, Foot and Mouth Disease
NCT03893747

Not yet recruiting

Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China

Conditions: Hand, Foot and Mouth Disease
NCT03873740

Completed

Immunogenicity and Safety of Two Different Commercial EV71 Vaccines

Conditions: Hand, Foot and Mouth Disease
NCT03830073

Not yet recruiting

Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene

Conditions: Acute Pancreatitis
NCT03804749

Recruiting

Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium

Conditions: Hand, Foot and Mouth Disease
NCT03737006

Active, not recruiting

Coxsackie Virus in Pregnancy and Congenital Heart Disease

Conditions: Congenital Heart Disease in Pregnancy
NCT03582761

Enrolling by invitation

Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71

Conditions: Hand, Foot and Mouth Disease
NCT03408587

Completed

CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)

Conditions: Uveal Melanoma; Liver Metastases
NCT03296410

Unknown status

The Phase IVd of Inactivated Enterovirus 71 Vaccine

Conditions: Hand, Foot and Mouth Disease (HFMD)
NCT03281174

Completed

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

Conditions: Hand, Foot and Mouth Disease
NCT03278132

Completed

Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine

Conditions: Hand, Foot and Mouth Disease
NCT03274102

Completed

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Conditions: Hand, Foot and Mouth Disease
NCT03266601

Completed

Effect of Recombinant Human Interferon α-2b Spray on Herpangina

Conditions: Herpangina
NCT03240744

Active, not recruiting

The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)

Conditions: Hand, Foot and Mouth Disease (HFMD)
NCT03241030

Unknown status

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial

Conditions: Herpangina; Gingivostomatitis; Hand, Foot and Mouth Disease
NCT03001986

Completed

The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Conditions: Hand, Foot and Mouth Disease (HFMD)
NCT02889497

Unknown status

Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months

Conditions: Hand Foot and Mouth Disease
NCT02565992

Completed

Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA)

Conditions: Melanoma
NCT02328651

Completed

Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease

Conditions: Handfoot-mouth Disease
NCT02316171

Completed

CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)

Conditions: Non-muscle Invasive Bladder Cancer
NCT02307149

Completed

Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)

Conditions: Melanoma
NCT02066714

Completed

Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam

Conditions: Hand Foot and Mouth Disease
NCT02001233

Completed

A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Conditions: Hand, Foot and Mouth Disease
NCT01940250

Completed

Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam

Conditions: Hand, Foot and Mouth Disease
NCT01769794

Completed

Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study

Conditions: Hand, Foot and Mouth Disease
NCT01636245

Completed

Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine

Conditions: Hand, Foot and Mouth Disease
NCT01636882

Completed

CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)

Conditions: Melanoma
NCT01554930

Completed

Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease

Conditions: Hand, Foot, and Mouth Disease
NCT01512706

Completed

A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Conditions: The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants
NCT01507857

Completed

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Conditions: Hand, Foot and Mouth Disease
NCT01508247

Completed

A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months

Conditions: Hand, Foot and Mouth Disease; Herpangina; Other EV71-associated Diseases
NCT01391494

Completed

A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants

Conditions: The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Adults, Children and Infants.
NCT01376479

Completed

Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71

Conditions: Hand, Foot and Mouth Disease
NCT01313715

Completed

A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants

Conditions: Hand, Foot, and Mouth Disease; Enterovirus Infections
NCT01302418

Completed

Collection and Testing of Respiratory Samples

Conditions: QIAGEN ResPlex II Advanced Panel; Influenza A; Respiratory Syncytial Virus Infections; Infection Due to Human Parainfluenza Virus 1; Parainfluenza Type 2; Parainfluenza Type 3; Parainfluenza Type 4; Human Metapneumovirus A/B; Rhinovirus; Coxsackie Virus/Echovirus; Adenovirus Types B/C/E; Coronavirus Subtypes 229E; Coronavirus Subtype NL63; Coronavirus Subtype OC43; Coronavirus Subtype HKU1; Human Bocavirus; Artus Influenza A/B RT-PCR Test; Influenza B
NCT01273246

Completed

Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children

Conditions: Hand-foot-mouth Disease; Infection; Viral, Enterovirus
NCT01267903

Completed

A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children

Conditions: Hand, Foot and Mouth Disease
NCT01255124

Completed

Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children

Conditions: Hand, Foot and Mouth Disease; Anti-EV71; Anti-CVA16
NCT01227551

Completed

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Conditions: Malignant Melanoma
NCT01182532

Completed

A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease

Conditions: Hand, Foot and Mouth Disease
NCT01182025

Unknown status

A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease

Conditions: Hand, Foot and Mouth Disease
NCT01175915

Unknown status

A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease

Conditions: Hand, Foot and Mouth Disease

COOKIE SETTINGS

Clinical Trials on Coxsackievirus Infections